TeleDocs360 review

Flat pricing has an advanced-dose exception

TeleDocs360 advertises semaglutide at $299 monthly and tirzepatide at $399 under flat-price wording. The same public page lists semaglutide at $349 for an advanced 2.0 mg weekly dose and tirzepatide at $649 for 12.5 or 15 mg weekly. Those higher charges mean the entry figure is not a universal all-dose rate. A prospective patient should obtain the price of the actual intended prescription, especially when transferring a continuing dose rather than starting a new course at an entry level.

The $250 difference between entry and advanced tirzepatide charges is substantial for a household budget. It does not establish that every patient will reach the advanced tier or that dose should be selected to fit a desired price. The clinician remains responsible for the prescription. Ask when the amount can change, how that is communicated before renewal and whether a change during an already paid period affects supply or billing. A flat-price slogan is less useful than a product-specific explanation that includes the published exception.

The included doctor, medication and shipping are meaningful

The quoted program describes the doctor, medication and shipping as included. That helps distinguish it from a care fee with a separately billed prescription, but it does not define every service a patient may need. Ask whether laboratory work, additional evaluations or unusual delivery arrangements create another charge. The actual supply and instructions should be identified with the price. A medication name alone cannot establish how long a shipment lasts or whether a new compounded preparation matches directions from an earlier provider.

Phentermine is offered at $149 monthly as a separate non-GLP-1 route. Its lower price should not be treated as another semaglutide tier or a substitute that can be chosen without clinical assessment. A clinician may discuss different treatments, but each proposed prescription needs a specific rationale, instructions and financial quote. The wider menu can support a conversation without making a low-cost alternative automatically appropriate or suggesting that adding another medicine improves a GLP-1 program.

The service details matter after the initial assessment

TeleDocs360 LLC is identified as the operating company, while the public information does not publish a state list or detailed cancellation policy. Confirm the consultation location and delivery eligibility before starting, and request the prescriber and pharmacy identities. The presence of an existing-patient portal does not establish the full enrollment or follow-up experience. Ask how questions reach the clinician, whether visits are scheduled and what happens when an issue needs more than an administrative message.

The public offering also does not establish a dedicated postpartum, breastfeeding or PCOS pathway. Relevant history and coordination should be discussed directly rather than inferred from a general weight-loss consultation. Before recurring payments begin, obtain the renewal date, stopping procedure and treatment of medication already being dispensed. TeleDocs360's strength is that the advanced-dose amounts are publicly visible even though they conflict with the flat-price wording. Its best comparison uses the actual dose tier and included care, with local access and exit terms clear, rather than extrapolating the entry charge across an assumed year of treatment. A current patient can ask for advance notice of a changed tier before another order is processed, rather than discover the increase afterward.